Canyon Clinical Trials
This following information about various clinical trials may contain uses for desirudin that have not been approved by the FDA or European regulatory agencies.  This site is not intended to promote such uses, but is offered to provide additional information about ongoing and completed studies for desirudin.  The safety and efficacy of desirudin for uses discussed in these clinical trials have not been established.  Please refer to the product’s complete prescribing information for information regarding approved indications, safety, efficacy and proper dosing.
 

PREVENT-HIT
A Comparative Clinical and Pharmacoeconomic Study Comparing Argatroban® IV vs. Desirudin SC for Patients with Suspected Heparin-Induced Thrombocytopenia (HIT) with or without Thrombosis Syndrome (HIT/TS)
http://www.clinicaltrials.gov/ct2/show/NCT00787332?term=Desirudin&rank=3

DESIRABLE
Multi-Center Desirudin Utilization Trial in Patients with or without Thrombosis Requiring an Alternative to Heparin-Based Anticoagulation
http://www.clinicaltrials.gov/ct2/show/NCT00913133?term=Desirudin&rank=2

Other Relevant Links

The Heart.org
The Heart.org is a source for cardiology news, commentary and continuing medical education sponsored by WebMD.
http://www.theheart.org

North American Thrombosis Forum
The North American Thrombosis Forum (NATF) is a multi-disciplinary organization founded with the objective of improving patient care through the advancement of thrombosis education. 
www.NATFonline.org

Coalition to Prevent DVT
The Coalition to Prevent DVT is a group of more than 50 organizations who have joined the Coalition in a united effort to raise awareness of DVT among consumers, healthcare professionals, policy-makers and public health leaders.
www.PreventDVT.org

European Thrombosis Research Organization
The objectives of ETRO include the furtherance in European countries of fundamental scientific research on all aspects of thrombosis.
http://www.etro.eu.org/